Zuanic & Associates' latest report outlines a roadmap for the SAFE Banking Act in the US cannabis industry, emphasizing the significance of rescheduling, US exchange uplisting, and a potential "Cole Memo II" (Garland Memo) as more critical catalysts than the SAFE Act itself.

Join us at the 17th Benzinga Cannabis Capital Conference in Chicago on September 27-28 for a chance to meet Pablo Zuanic, chief analyst at Zuanic & Associates.

On The Cole Memo II

Road Steps And Catalysts Ahead

According to Zuanic, delays in the mark-up vote could, potentially, signify positive developments. The SAFE Act filed jointly in both the House and Senate in 2023, has gained bipartisan support, and the delays may be aimed at securing more votes.

The report outlines key steps and potential catalysts …

Full story available on Benzinga.com

A note to our visitors

This website has updated its privacy policy in compliance with changes to European Union data protection law, for all members globally. We’ve also updated our Privacy Policy to give you more information about your rights and responsibilities with respect to your privacy and personal information. Please read this to review the updates about which cookies we use and what information we collect on our site. By continuing to use this site, you are agreeing to our updated privacy policy.